论文部分内容阅读
目的:探讨米非司酮配伍米索前列醇终止早期妊娠的临床效果。方法:选取我院妇产科2010年7月～2012年4月收诊的218例早期妊娠并自愿要求终止妊娠孕妇为研究对象,随机分为治疗组和对照组,治疗组给予米非司酮配伍米索前列醇流产,对照组给予米非司酮流产,观察对比两组患者的引产成功率、平均出血量以及不良反应发生率。结果:治疗组的引产成功率明显高于对照组,平均出血量和不良反应发生率明显低于对照组。结论:米非司酮配伍米索前列醇终止早期妊娠有效安全,引产成功率较高,建议在临床上大力推广使用。
Objective: To investigate the clinical effect of mifepristone combined with misoprostol to terminate early pregnancy. Methods: 218 cases of early pregnancy admitted to our hospital from July 2010 to April 2012 were enrolled in the study. Pregnant women were randomly divided into treatment group and control group. The treatment group was given mifepristone Misoprostol compatibility abortion, the control group were given mifepristone abortion, observed and compared the success rate of induction of labor in both groups, the average amount of bleeding and the incidence of adverse reactions. Results: The success rate of induction of labor in the treatment group was significantly higher than that in the control group, the average amount of bleeding and the incidence of adverse reactions was significantly lower than the control group. Conclusion: Mifepristone combined with misoprostol to terminate early pregnancy effective and safe, high success rate of induction of labor, it is recommended to promote the use of clinically.